Human Immune Responses to Infection and Vaccination
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Clinical Immunology".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 121
Special Issue Editors
Interests: vaccine-induced immune response; adjuvants; immune regulation; immunotoxicology of vaccines
Interests: vaccines; regulatory response; preclinical developments
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Developing effective preventive strategies against infectious diseases demands a thorough and robust understanding of human immune responses to infection and vaccination. This area of research delves into the intricate mechanisms involved in generating protective immune responses against pathogens for vaccine development. Recent research in this field has focused on developing innovative vaccine platforms and cutting-edge technologies (such as mRNA vaccines and viral vectors), as well as the use of new adjuvants to create next-generation vaccines with enhanced efficacy and safety. Additionally, immune regulation research explores ways to fine-tune the immune system in order to achieve optimal vaccine performance and eliminate undesirable side effects. Translational vaccinology aims to bridge the gap between basic research and clinical application, expediting the transition from bench to bedside. Another crucial area of research is centered around identifying measurable indicators or correlates that predict individual and herd protection. Therefore, understanding the dynamics of herd immunity is critical for shaping vaccination strategies at the population level. This Special Issue seeks original research articles and reviews on these and related topics.
We look forward to receiving your contributions.
Prof. Dr. Alexander Batista-Duharte
Dr. Gabriel Cabrera
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine immunogenicity
- adjuvants
- new generation of vaccines
- vaccine development
- immune regulation
- translational vaccinology
- system vaccinology
- herd immunity
- vaccine safety
- correlates of protection
